Saliva-based genome testing
New Delhi: Lord’s Mark Industries has launched wholly owned subsidiary Lord’s Mark Microbiotech to promote genome testing in India. Their brand MyDNA introduces saliva-based technology with 99 per cent accuracy, eliminating the need for blood extraction. The subsidiary aims to make genomic products and technology accessible nationwide through healthcare providers. “Genome testing is an exciting new area with the potential to revolutionise healthcare in India,” said Sachidanand Upadhyay, founder of Lord’s Mark Industries.